June 2010: Kuros completes recruitment in Phase IIb study of KUR-113 (auf Deutsch)
Zurich, Switzerland, 2nd June 2010 - Kuros Biosurgery AG, a biotechnology company focused on the...

March 2010: KUR-111 meets primary efficacy endpoint in Phase IIb study (auf Deutsch)
Zurich, Switzerland, 15th March 2010 - Kuros Biosurgery AG announced today the results of a...

August 2009: Kuros announces encouraging Phase IIa data with KUR-212 in patients with burns requiring mesh grafting (auf Deutsch)
Zurich, Switzerland, 12h August 2009 - Kuros Biosurgery AG announced today the final results of...